| Literature DB >> 33803863 |
Katharina Rall1, Bernadette Schenk1, Norbert Schäffeler2, Dorit Schöller1, Andrina Kölle1, Birgitt Schönfisch1, Sara Y Brucker1.
Abstract
The Mayer-Rokitansky-Küster-Hauser-syndrome (MRKHS) is characterized by a congenital uterine and vaginal aplasia. A large body of literature reports that a diagnosis of MRKHS has a variety of psychological effects on patients and doubts about female identity. The aim of the underlying study was to detect the patient-reported physical and mental health and sexual function before and after laparoscopically assisted creation of a neovagina. 160 women with MRKHS who underwent this type of surgery between September 2009 and December 2015 were invited to complete the questionnaires. Packages consisting of six questionnaires were handed out before surgery, six and 12 months after surgery. Data from 82 patients could be included in the study. Patients had a mean age of 19.9 years at inclusion in the study. We detected an impairment of the health-related mental quality of life. There was no higher risk for psychological disorders. MRKHS patients show similar self-acceptance and normal body image compared to the general population. The sexual function is limited before surgery and normalizes after surgery. Useful factors for coping with the disease are an interdisciplinary approach in diagnostics and treatment, psychosocial adaptation as well as a supportive social environment.Entities:
Keywords: MRKHS; depression; infertility; mental health; physical health; quality of life; sexuality
Year: 2021 PMID: 33803863 PMCID: PMC8003280 DOI: 10.3390/jcm10061269
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Sociodemographic data of MRKHS patients (data collected TP1-3).
| Demographic Data | TP1 | TP2 | TP3 | |||
|---|---|---|---|---|---|---|
|
| M (SD) |
| M (SD) |
| M (SD) | |
| Age (years) | 82 | 19.9 (5.3) a | 82 | 20.6 (5.3) a | 56 | 21.4 (4.6) b |
| Average height (cm) | 82 | 166.8 (6.7) | 82 | 167.2 (6.6) | 56 | 167.1 (7.1) |
| Average weight (kg) | 82 | 60.7 (11.9) | 82 | 61.9 (12.1) | 56 | 62.1 (12.3) |
| BMI (kg/m2) | 82 | 21.3 (4.3) | 82 | 22.2 (4.5) | 56 | 22.6 (4.1) |
| N | N | N | ||||
| Country of birth, patients | 81 | |||||
| Germany | 73 (90%) | |||||
| other | 8 (10%) | |||||
| Country of birth, parents | 81 | |||||
| Germany | 65 (80%) | |||||
| One parent from foreign country | 5 (6%) | |||||
| Both parents from foreign country | 11 (14%) | |||||
| Number of siblings | 79 | |||||
| sisters | ||||||
| 0 | 37 (47%) | |||||
| 1 | 35 (44%) | |||||
| 2 | 7 (9%) | |||||
| brothers | ||||||
| 0 | 38 (48%) | |||||
| 1 | 25 (32%) | |||||
| 2 | 10 (13%) | |||||
| 3 | 5 (6%) | |||||
| 4 | 1 (1%) | |||||
| Living situation: I live | 82 | 82 | 55 | |||
| with my parents | 66 (81%) | 65 (79%) | 36 (66%) | |||
| alone in a flat | 5 (6%) | 9 (11%) | 5 (9%) | |||
| with others in a shared flat | 2 (2%) | 3 (4%) | 5 (9%) | |||
| with my girl-/boyfriend in a flat | 9 (11%) | 5 (6%) | 9 (16%) | |||
| Highest school degree | 73 | 81 | 55 | |||
| none | 10 (14%) | 5 (6%) | 3 (5%) | |||
| secondary modern school | 12 (16%) | 12 (15%) | 4 (7%) | |||
| junior high school | 30 (41%) | 30 (37%) | 16 (29%) | |||
| final secondary school exam | 17 (23%) | 27 (33%) | 29 (53%) | |||
| university degree | 4 (6%) | 7 (9%) | 3 (6%) | |||
| Actual profession | 78 | 82 | 55 | |||
| unemployed | 1 (1%) | 2 (2%) | 0 | |||
| scholar | 41 (53%) | 36 (44%) | 19 (35%) | |||
| trainee | 13 (17%) | 18 (22%) | 15 (27%) | |||
| student | 4 (5%) | 6 (7%) | 10 (18%) | |||
| employee | 14 (18%) | 15 (18%) | 10 (18%) | |||
| officer | 0 | 0 | 0 | |||
| self-employed | 0 | 0 | 0 | |||
| others | 5 (6%) | 5 (6%) | 1 (2%) | |||
Notes: a age span from 17 and 40 years. b age span from 18 to 44 years.
Cyclic complaints.
| Complaints | TP1 | TP2 | TP3 |
|---|---|---|---|
| Do you suffer from cyclic discomfort (regular monthly complaints for 1–3 days)? | |||
| mastodynia | 16 (21%) | 16 (20%) | 16 (29%) |
| Mittelschmerz/lower abdominal pain | 30 (39%) | 24 (30%) | 13 (24%) |
| irritability | 16 (21%) | 24 (30%) | 14 (26%) |
| discharge | 4 (5%) | 2 (3%) | 8 (15%) |
| ravenousness | 15 (19%) | 18 (23%) | 13 (24%) |
| swollen abdomen | 16 (21%) | 15 (19%) | 10 (18%) |
| other cyclic complaints | 8 (9%) | 2 (3%) | 3 (6%) |
| no complaints | 34 (44%) | 35 (44%) | 23 (42%) |
Sexual contacts, sexual partners, sexual intercourse (different patient numbers show different rates of completed questions).
| Sexuality | TP1 | TP2 | TP3 |
|---|---|---|---|
| Are you actually sexually active? | |||
| Have you ever had sexual intercourse? | |||
| No | 45 (61%) | 28 (34%) | 9 (16%) |
| yes | 29 (39%) | 54 (66%) | 46 (84%) |
| Which type of sexual contact do you have? | n = 27 | ||
| petting | 16 (59%) | ||
| sexual intercourse | 4 (15%) | ||
| both | 7 (26%) | ||
| Did you have more than one sexual partner after surgery? | |||
| No | 48 (92%) | 27 (59%) | |
| yes | 4 (8%) | 19 (41%) | |
| Number of sexual partners since surgery | |||
| 2 | 5 (100%) | 9 (50%) | |
| 3 | 0 | 5 (28%) | |
| 4 | 0 | 3 (17%) | |
| 12 | 0 | 1 (6%) | |
| How do you orgasm? | |||
| (day)dreams | 5 (6%) | 3 (5%) | |
| masturbation | 23 (28%) | 28 (50%) | |
| petting | 32 (39%) | 30 (54%) | |
| sexual intercourse without petting | 17 (21%) | 22 (39%) | |
| sexual intercourse with petting | 42 (51%) | 35 (63%) | |
| never | 13 (16%) | 5 (9%) |
Causes for stress associated with the MRKHS diagnosis.
| Causes for Stress | TP1 | TP2 | TP3 |
|---|---|---|---|
| Which topics stress you the most associated with MRKHS? | |||
| unwanted childlessness | 64 (78%) | 71 (87%) | 53 (96%) |
| therapy/surgery | 49 (60%) | 16 (20%) | 11 (20%) |
| wish for a fulfilled partnership | 33 (40%) | 35 (43%) | 17 (31%) |
| wish for a satisfying sexual life | 33 (40%) | 40 (49%) | 14 (26%) |
| my self-esteem | 28 (34%) | 24 (29%) | 20 (36%) |
| mother-daughter relation | 4 (5%) | 6 (7%) | 9 (16%) |
| to be physically different from my friends | 31 (38%) | 30 (37%) | 24 (44%) |
| to be different from other women | 23 (28%) | 22 (27%) | 17 (31%) |
| other topics | 2 (2%) | 2 (2%) | 7 (13%) |
Figure 1Grade of stress due to infertility. Dark grey bars represent TP2 (n = 82), the light grey bars TP3 (n = 55).
Descriptive evaluation and Wilcoxon signed-rank test of the continuous scales (PHQ-D) compared to the values from two reference samples.
| Continuous Scales | n | M (SD) | Mdn | Min | Max | |
|---|---|---|---|---|---|---|
| somatic symptoms | ||||||
| TP1 | 81 | 5.4 (4.2) | 5 | 0 | 16 | |
| TP2 | 80 | 4.8 (4.0) | 4 | 0 | 19 | |
| TP3 | 55 | 5.4 (5.2) | 4 | 0 | 28 | |
| 1 healthy | 357 | 6.4 (3.9) | 0.014 *, <0.001 *, 0.032 * | |||
| 2 mental disorders | 171 | 9.8 (5.4) | <0.001 *, <0.001 *, <0.001 * | |||
| depression | ||||||
| TP1 | 81 | 5.6 (4.2) | 5 | 0 | 17 | |
| TP2 | 79 | 3.8 (3.8) | 3 | 0 | 20 | |
| TP3 | 55 | 4.0 (4.6) | 3 | 0 | 24 | |
| 1 healthy | 357 | 5.9 (4.2) | 0.294, <0.001 *, <0.001 * | |||
| 2 mental disorders | 171 | 11.7 (5.0) | <0.001 *, <0.001 *, <0.001 * | |||
| stress | ||||||
| TP1 | 81 | 4.4 (3.3) | 4 | 0 | 14 | |
| TP2 | 79 | 3.6 (3.1) | 3 | 0 | 13 | |
| TP3 | 55 | 4.2 (3.3) | 4 | 0 | 15 |
Notes: Wilcoxon signed-rank test. * p-value < 0.05. 1,2 reference sample: Gräfe et al. [28].
Frequency and rates of the scores for different manifestations of the somatic symptoms value (PHQ-15) and frequency and rate of values for the different manifestations of depression (PHQ-8 and PHQ-9).
| Scores and Values | TP1 | TP2 | TP3 |
|---|---|---|---|
| Score of somatic symptoms | |||
| 0 to 4 (minimal) | 40 (49%) | 43 (54%) | 30 (55%) |
| 5 to 9 (mild) | 28 (35%) | 29 (36%) | 14 (26%) |
| 10 to 14 (moderate) | 9 (11%) | 5 (6%) | 9 (16%) |
| 15 to 30 (severe) | 4 (5%) | 3 (4%) | 2 (4%) |
| Value for depression | |||
| <5 (no depressive disorder) | 35 (43%) | 54 (68%) | 36 (66%) |
| 5 to 9 (mild or subliminal depressive disorder) | 33 (41%) | 19 (24%) | 15 (27%) |
| ≥10 (major depression) | 13 (16%) | 6 (8%) | 4 (7%) |
| 10 to 14 (moderate “major depression”) | 11 (14%) | 4 (5%) | 2 (4%) |
| 15 to 19 (pronounced “major depression”) | 2 (3%) | 1 (1%) | 1 (2%) |
| 20 to 24 (severe “major depression”) | 0 | 1 (1%) | 1 (2%) |
Frequency and rates of the categorial scales and Chi-square test for equal distribution for the comparison of the categorial scales with the reference sample by Jacobi et al. (PHQ-D).
| Categorial Scales | TP1 | TP2 | TP3 | Reference Sample | |
|---|---|---|---|---|---|
| [ | (TP1, TP2, TP3) | ||||
|
|
| ||||
| somatoform syndrome | 6 (7%) | 3 (4%) | 5 (9%) | 15% | 0.053, 0.004 *, 0.209 |
| major depressive syndrome | 4 (5%) | 2 (2%) | 3 (5%) | 10% | 0.153, 0.029 *, 0.290 |
| other depressive syndromes | 13 (16%) | 3 (4%) | 1 (2%) | ||
| panic syndrome | 2 (2%) | 0 | 1 (2%) | 3% | 0.631, unk, 0.505 |
| other anxiety syndromes | 2 (2%) | 2 (2%) | 1 (2%) | ||
| suspected Bulimia nervosa | 1 (1%) | 3 (4%) | 1 (2%) | 1% ° | |
| suspected Binge eating disorder | 4 (5%) | 10 (12%) | 4 (7%) | ||
| alcohol syndrome | 17 (21%) | 5 (6%) | 2 (4%) | 2% | <0.001 *, 0.005, 0.359 |
Notes: * p-value < 0.05. ° suspected Bulimia nervosa and Binge eating disorder together.
Figure 2Overview over the distribution of the RBI scores (FKB-20). notes: black bars represent the RBI score at TP1 (n = 82), light grey bars at TP2 (n = 80) and dark grey bars at TP3 (n = 55).
Descriptive evaluation and Wilcoxon signed-rank test of the RBI scale (FKB-20) compared to two reference sample groups and descriptive analysis of the VBD (FKB-20) including the two reference samples and Student-t test including the Cut-off values.
| TP and Reference Samples | n | M (SD) | Mdn | Min | Max | |
|---|---|---|---|---|---|---|
| RBI | ||||||
| TP1 | 82 | 24.1 (9.0) | 22 | 10 | 48 | |
| TP2 | 80 | 22.8 (8.2) | 21 | 10 | 49 | |
| TP3 | 55 | 22.0 (7.7) | 20 | 12 | 44 | |
| 1 medical students | 56 | 20.6 (7.1) | 18 | 11 | 42 | <0.001 *, <0.001 *, <0.001 * |
| 2 patients | 253 | 27.1 (8.7) | 26 | 12 | 50 | 0.013 *, <0.001 *, <0.001 * |
| VBD | ||||||
| TP1 | 82 | 33.2 (6.6) | 34 | 14 | 47 | |
| TP2 | 78 | 33.7 (6.6) | 34 | 18 | 50 | |
| TP3 | 55 | 33.4 (6.5) | 33 | 16 | 45 | |
| 1 medical students | 304 | 36.6 (5.8) | 37 | 19 | 48 | <0.001 *, <0.001 *, <0.001 * |
| 2 patients | 224 | 27.0 (7.4) | 27 | 19 | 48 | <0.001 *, <0.001 *, <0.001 * |
| Cut off for body image disturbance: <31 | 0.001 *, <0.001 *, 0.004 * |
Notes: VBD = vital body dynamics, Student-t test. * p-value < 0.05. 1,2 reference sample: Clement et al. [23]. notes: RBI = rejecting body evaluation. Wilcoxon signed-rank test. * p-value < 0.05. 1,2 reference sample: Clement et al. [23].
Figure 3Overview over the VBD scores (FKB-20). notes: black bars represent the VBD score at TP1 (n = 82), light grey bars at TP2 (n = 78) and dark grey bars at TP3 (n = 55).
Descriptive analysis of the individual scores (FSFI-d) compared to the reference sample and Wilcoxon signed-rank test of the FSFI-d domain scores and descriptive analysis of the total scores in comparison with the reference sample (FSFI-d) and Wilcoxon signed-rank test of the FSFI-d total scores.
| Domains, Single Scores |
| M (SD) | Mdn | Min | Max | |
|---|---|---|---|---|---|---|
| desire | ||||||
| TP1 | 76 | 3.3 (1.2) | 3.6 | 1.2 | 6 | <0.001 * |
| TP2 | 76 | 3.7 (1.2) | 3.6 | 1.2 | 6 | 0.034 * |
| TP3 | 55 | 3.7 (1.2) | 3.6 | 1.2 | 6 | 0.01 |
| reference sample 1 | 131 | 4.1 (1.1) | ||||
| arousal | ||||||
| TP1 | 68 | 3.0 (2.2) | 3.8 | 0 | 6 | <0.001 * |
| TP2 | 69 | 4.0 (2.1) | 5.1 | 0 | 6 | 0.036 * |
| TP3 | 52 | 4.1 (2.0) | 4.8 | 0 | 6 | 0.018 * |
| reference sample 1 | 130 | 5.0 (1.1) | ||||
| lubrication | ||||||
| TP1 | 70 | 3.2 (2.6) | 4.5 | 0 | 6 | <0.001 * |
| TP2 | 70 | 4.6 (2.3) | 5.7 | 0 | 6 | 0.095 |
| TP3 | 51 | 4.5 (2.3) | 5.7 | 0 | 6 | 0.012 * |
| reference sample 1 | 130 | 5.6 (1.0) | ||||
| orgasm | ||||||
| TP1 | 66 | 2.4 (2.2) | 2.8 | 0 | 6 | <0.001 * |
| TP2 | 67 | 3.9 (2.1) | 4.8 | 0 | 6 | <0.001 * |
| TP3 | 51 | 3.7 (2.2) | 4.8 | 0 | 6 | <0.001 * |
| reference sample 1 | 129 | 5.1 (1.3) | ||||
| global satisfaction | ||||||
| TP1 | 50 | 3.9 (1.7) | 4 | 0.8 | 6 | 1 |
| TP2 | 56 | 5.2 (1.1) | 5.6 | 1.6 | 6 | 0.019 * |
| TP3 | 39 | 5.2 (1.0) | 5.6 | 1.6 | 6 | 0.128 |
| reference sample 1 | 130 | 5.1 (1.2) | ||||
| pain | ||||||
| TP1 | 66 | 0.8 (1.5) | 0 | 0 | 6 | <0.001 * |
| TP2 | 69 | 2.4 (2.1) | 2 | 0 | 6 | <0.001 * |
| TP3 | 49 | 3.7 (2.1) | 4 | 0 | 6 | 1 |
| reference sample 1 | 130 | 5.7 (1.1) | ||||
| FSFI-d-Total Score | n | M (SD) | Mdn | Min. | Max. | |
| TP1 | 41 | 19.0 (8.8) | 20.8 | 2 | 33.6 | <0.001 * |
| TP2 | 51 | 27.2 (4.7) | 27.9 | 11.3 | 35.7 | <0.001 * |
| TP3 | 38 | 28.3 (5.3) | 28.4 | 5.2 | 36 | 0.007 * |
| reference sample 1 | 129 | 30.5 (5.3) |
Notes: Wilcoxon signed-rank test. * p-value < 0.05. 1 reference sample: Rosen et al. [24].
Figure 4Distribution of the FSFI-d total scores. notes: black bars represent the FSFI-d total score at TP1 (n = 41), the light grey bars the FSFI-d total score at TP2 (n = 51) and the dark grey bars at TP3 (n = 38).
Frequency and percentages of the FSFI-d total scores representing grades of sexual dysfunction.
| FSFI-d Total Score | TP1 | TP2 | TP3 |
|---|---|---|---|
| Wiegel et al. (106) | |||
| <26.55 (sexual dysfunction) | 33 (80%) | 25 (49%) | 13 (34%) |
| >26.55 (normal sexual function) | 8 (20%) | 26 (51%) | 25 (66%) |
| Communal et al. (107) | |||
| ≤23 (severe sexual dysfunction) | 26 (63%) | 7 (14%) | 4 (10%) |
| 24–29 (moderate sexual dysfunction) | 14 (34%) | 30 (59%) | 19 (50%) |
| ≥30 (normal sexual function) | 1 (2%) | 14 (27%) | 15 (40%) |
Descriptive analysis and Wilcoxon signed-rank test for the PCS and for the MCS of the SF-12 compared to one healthy and one chronically ill reference sample stratified by age.
| TP and Reference Samples | n | M (SD) | Mdn | Min | Max | |
|---|---|---|---|---|---|---|
|
| ||||||
| TP1 | 73 | 55.9 (5.1) | 56.1 | 37.3 | 65.4 | |
| TP2 | 76 | 54.7 (5.0) | 55.9 | 36.6 | 62.4 | |
| TP3 | 49 | 54.8 (5.8) | 55.4 | 26.1 | 63.3 | |
| 1 healthy | 123 | 54.0 (5.9) | 35 | 63.7 | <0.001 *, <0.001 *, 0.003 * | |
| 2 healthy | 473 | 52.9 (6.8) | 16.2 | 62.8 | <0.001 *, <0.001 *, <0.001 * | |
| 3 chronically ill | 46 | 52.4 (7.5) | 35 | 63.7 | <0.001 *, <0.001 *, <0.001 * | |
| 4 chronically ill | 227 | 51.1 (8.6) | 16.2 | 62.8 | <0.001 *, <0.001 *, <0.001 * | |
|
| ||||||
| TP1 | 73 | 42.3 (11.8) | 45.6 | 15.9 | 57.8 | |
| TP2 | 76 | 46.7 (10.3) | 49.8 | 12.2 | 59.9 | |
| TP3 | 49 | 46.7 (10.9) | 51.2 | 22 | 57.9 | |
| 1 healthy | 123 | 52.6 (9.1) | 12.6 | 62 | <0.001 *, <0.001 *, 0.005 * | |
| 2 healthy | 473 | 51.9 (8.4) | 16.4 | 71.8 | <0.001 *, <0.001 *, 0.023 * | |
| 3 chronically ill | 46 | 49.4 (11.1) | 12.6 | 62 | <0.001 *, 0.230, 0.327 | |
| 4 chronically ill | 227 | 50.3 (9.5) | 16.4 | 71.8 | <0.001 *, 0.031 *, 0.158 |
Notes: Wilcoxon signed-rank test. * p-value < 0.05.1,2 reference sample healthy: 14–20 years of age, 21–30 years of age, Bullinger et al. [26]. 3,4 reference sample chronically ill: 14–20 years of age, 21–30 years of age, Bullinger et al. [26].
Descriptive analysis and Wilcoxon signed-rank test of the SESA total score compared to the healthy and depressive reference samples.
| TP and Reference Samples |
| M (SD) | Mdn | Min | Max | |
|---|---|---|---|---|---|---|
| SESA total score | ||||||
| TP1 | 73 | 107.0 (20.6) | 110 | 47 | 141 | |
| TP2 | 65 | 107.1 (23.5) | 111 | 50 | 144 | |
| TP3 | 52 | 108.0 (22.4) | 111 | 43 | 142 | |
| 1 healthy | 311 | 112.3 (15.9) | 0.045 *, 0.125, 0.173 | |||
| 2 depressive | 45 | 86.1 (18.8) | <0.001 *, <0.001 *, <0.001 * |
Notes: Wilcoxon signed-rank test. * p-value < 0.05. 1,2 reference sample: Sorembe et al. [27].
Frequencies of the indicators of the SESA total score.
| Grade of Self-Acceptance | TP1 | TP2 | TP3 |
|---|---|---|---|
| Normal self-acceptance | 51 (70%) | 46 (71%) | 36 (69%) |
| Moderate self-acceptance | 15 (20%) | 7 (11%) | 9 (17%) |
| Indicator for low self-acceptance | 7 (10%) | 12 (18%) | 7 (14%) |
SESA indicators over the time.
| Pat. No | TP1 | TP2 | TP3 |
|---|---|---|---|
| 2 | 102 | 97 | 73 |
| 3 | 87 | 89 | 93 |
| 5 | 83 | 84 | 73 |
| 6 | * | 73 | * |
| 8 | 87 | 72 | 129 |
| 9 | 83 | 71 | 43 |
| 11 | 87 | 106 | 91 |
| 12 | 120 | 124 | 96 |
| 13 | 100 | 115 | 94 |
| 15 | 94 | 73 | 100 |
| 17 | 111 | 131 | 82 |
| 18 | 76 | 76 | 85 |
| 20 | 101 | 107 | 89 |
| 23 | 82 | 114 | 106 |
| 28 | * | * | 72 |
| 29 | 88 | * | 96 |
| 34 | 84 | 99 | 99 |
| 36 | 76 | 63 | 85 |
| 38 | 72 | 78 | 71 |
| 43 | 59 | 59 | 73 |
| 48 | 73 | 94 | 97 |
| 54 | 93 | 70 | 73 |
| 59 | 82 | 108 | ** |
| 62 | 104 | 88 | ** |
| 68 | 107 | 86 | ** |
| 70 | 85 | 106 | ** |
| 71 | 75 | 80 | ** |
| 73 | 111 | 57 | ** |
| 76 | 95 | 110 | ** |
| 77 | 92 | * | ** |
| 78 | 91 | 96 | ** |
| 79 | 47 | 50 | ** |
| 81 | 108 | 91 | ** |
Notes: White represents normal self-acceptance, light grey represents moderate self-acceptance and grey means indicator for low welf-acceptance. * questionnaire excluded, because more than two answers are missing. ** no completed questionnaire.